Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 24599305)

1.

Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.

Lee SY, Haq F, Kim D, Jun C, Jo HJ, Ahn SM, Lee WS.

PLoS One. 2014 Mar 5;9(3):e90459. doi: 10.1371/journal.pone.0090459. eCollection 2014.

2.

Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.

Kern A, Taubert H, Scheele J, Rudroff C, Mothes H, Kappler M, Bartel F, Richter KK.

Int J Oncol. 2002 Aug;21(2):243-9.

PMID:
12118317
3.

Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.

Sawada T, Yamamoto E, Suzuki H, Nojima M, Maruyama R, Shioi Y, Akasaka R, Kamimae S, Harada T, Ashida M, Kai M, Adachi Y, Yamamoto H, Imai K, Toyota M, Itoh F, Sugai T.

Genes Chromosomes Cancer. 2013 Feb;52(2):140-9. doi: 10.1002/gcc.22013. Epub 2012 Oct 17.

PMID:
23073979
4.

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

Vakiani E, Janakiraman M, Shen R, Sinha R, Zeng Z, Shia J, Cercek A, Kemeny N, D'Angelica M, Viale A, Heguy A, Paty P, Chan TA, Saltz LB, Weiser M, Solit DB.

J Clin Oncol. 2012 Aug 20;30(24):2956-62. doi: 10.1200/JCO.2011.38.2994. Epub 2012 Jun 4.

5.

Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.

Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S.

BMC Cancer. 2008 Jul 1;8:187. doi: 10.1186/1471-2407-8-187.

6.

P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.

Yang Y, Forslund A, Remotti H, Lönnroth C, Andersson M, Brevinge H, Svanberg E, Lindnér P, Hafström L, Naredi P, Lundholm K.

Cancer. 2001 Feb 15;91(4):727-36.

PMID:
11241240
7.

Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer.

Kloosterman WP, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat JS, van Roosmalen MJ, van Lieshout S, Nijman IJ, Roessingh W, van 't Slot R, van de Belt J, Guryev V, Koudijs M, Voest E, Cuppen E.

Genome Biol. 2011 Oct 19;12(10):R103. doi: 10.1186/gb-2011-12-10-r103.

8.

Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.

Shanmugam V, Ramanathan RK, Lavender NA, Sinari S, Chadha M, Liang WS, Kurdoglu A, Izatt T, Christoforides A, Benson H, Phillips L, Baker A, Murray C, Hostetter G, Von Hoff DD, Craig DW, Carpten JD.

BMC Med Genomics. 2014 Jun 18;7:36. doi: 10.1186/1755-8794-7-36.

9.

There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability.

Barnetson R, Eckstein R, Robinson B, Schnitzler M.

Genes Chromosomes Cancer. 2003 Oct;38(2):149-56.

PMID:
12939742
10.

Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.

Neumann J, Wehweck L, Maatz S, Engel J, Kirchner T, Jung A.

Virchows Arch. 2013 Oct;463(4):509-23. doi: 10.1007/s00428-013-1450-0. Epub 2013 Aug 10.

PMID:
23934607
11.

Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays.

Muñoz-Bellvis L, Fontanillo C, González-González M, Garcia E, Iglesias M, Esteban C, Gutierrez ML, Abad MM, Bengoechea O, De Las Rivas J, Orfao A, Sayagués JM.

Mod Pathol. 2012 Apr;25(4):590-601. doi: 10.1038/modpathol.2011.195. Epub 2012 Jan 6.

12.

Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.

Maurer CA, Graber HU, Friess H, Beyermann B, Willi D, Netzer P, Zimmermann A, Büchler MW.

Surgery. 1999 Nov;126(5):869-80.

PMID:
10568187
13.

KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.

Balschun K, Haag J, Wenke AK, von Schönfels W, Schwarz NT, Röcken C.

J Mol Diagn. 2011 Jul;13(4):436-45. doi: 10.1016/j.jmoldx.2011.03.002. Epub 2011 May 4.

14.

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.

de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.

Clin Cancer Res. 2005 Jun 1;11(11):4067-73.

15.

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.

Ouyang L, Lee J, Park CK, Mao M, Shi Y, Gong Z, Zheng H, Li Y, Zhao Y, Wang G, Fu H, Kim J, Lim HY.

BMC Med Genomics. 2014 Jan 9;7:2. doi: 10.1186/1755-8794-7-2.

16.

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.

Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald S, O'Connor L, Wilding JL, Bicknell D, Tomlinson IP, Bodmer WF, Mariadason JM, Sieber OM.

Cancer Res. 2014 Jun 15;74(12):3238-47. doi: 10.1158/0008-5472.CAN-14-0013. Epub 2014 Apr 22.

PMID:
24755471
17.

Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases.

Al-Mulla F, Keith WN, Pickford IR, Going JJ, Birnie GD.

Genes Chromosomes Cancer. 1999 Apr;24(4):306-14.

PMID:
10092128
18.

Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors.

Goranova TE, Ohue M, Shimoharu Y, Kato K.

Clin Exp Metastasis. 2011 Jun;28(5):427-35. doi: 10.1007/s10585-011-9381-0. Epub 2011 Mar 5.

19.

The status of p53 in the metastatic progression of colorectal cancer.

Heide I, Thiede C, Sonntag T, de Kant E, Neubauer A, Jonas S, Peter FJ, Neuhaus P, Herrmann R, Huhn D, Rochlitz CF.

Eur J Cancer. 1997 Jul;33(8):1314-22.

PMID:
9301461
20.

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.

Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE.

Clin Cancer Res. 2010 Feb 1;16(3):790-9. doi: 10.1158/1078-0432.CCR-09-2446. Epub 2010 Jan 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk